Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta‐analysis of case series studies
2012
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
The role of cytoreductive nephrectomy in the era of molecular targeted therapy
2009
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Matched Comparison of Radical Nephrectomy vs Nephron-Sparing Surgery in Patients With Unilateral Renal Cell Carcinoma and a Normal Contralateral Kidney
2000
A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma
2006
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
2012
INTRAOPERATIVE, PERIOPERATIVE, AND LONG-TERM COMPLICATIONS OF RADICAL PROSTATECTOMY
2001
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?
2006
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate‐specific antigen testing: 15‐year outcome
2005
The management of PSA failure after radical radiotherapy for localized prostate cancer
1998
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
2003
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
Renal cell carcinoma
2009
Epidemiology of prostate cancer
1997
Salvage brachytherapy for localized prostate cancer after radiotherapy failure
1999
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
2006 Standout
Laparoscopic partial nephrectomy for renal masses: Effect of tumor location
2006
Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography
2004
PREDICTORS OF RENAL TRANSPLANT HISTOLOGY AT THREE MONTHS
1999
Robot-assisted versus open radical prostatectomy: a comparison of one surgeon's outcomes
2004 StandoutNobel
Contemporary evaluation of operative parameters and complications related to open radical retropubic prostatectomy
2003
Y‐27632, an inhibitor of Rho‐kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum
2001
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Morbidity and Clinical Outcome of Nephron-Sparing Surgery in Relation to Tumour Size and Indication
2007
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Cancer Volume of Lymph Node Metastasis Predicts Progression in Prostate Cancer
1998
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Prognostic Implication of Microvascular Invasion in Biochemical Failure in Patients Treated with Radical Prostatectomy
2003
Conformity index: A review
2006 Standout
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology
2003
The natural history of incidentally detected small renal masses
2004
von Hippel-Lindau disease
2003 Standout
Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy
2003
The Natural History of Chronic Allograft Nephropathy
2003 Standout
Radical perineal prostatectomy in obese patients
2003
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2015 Standout
Oral Sildenafil in the Treatment of Erectile Dysfunction
1998 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
Nephron-Sparing Surgery for Renal Cell Carcinoma: Detailed Analysis of Complications Over a 15-Year Period
2006
A Pretreatment Table for the Prediction of Final Histopathology after Radical Prostatectomy in Clinical Unilateral T3a Prostate Cancer
2006
Prevention of Venous Thromboembolism
2004 Standout
Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells
1998
Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program
2000
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study
2006 Standout
Fibromuscular dysplasia
2005
An Analysis of Radical Prostatectomy in Advanced Stage and High-Grade Prostate Cancer
2007
Optimal Margin in Nephron-Sparing Surgery for Renal Cell Carcinoma 4 cm or Less
2003
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Influence of body weight and prostate volume on intraoperative, perioperative, and postoperative outcomes after radical retropubic prostatectomy
2003
Prevention of Venous Thromboembolism
2008 Standout
The renal allograft biopsy
1996
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
2015 Standout
Comparison of direct hospital costs and length of stay for radical nephrectomy versus nephron-sparing surgery in the management of localized renal cell carcinoma
1999
Interstitial photodynamic therapy for prostate cancer: a developing modality
2004
Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications
2005 Standout
Outcomes after adjuvant chemotherapy in the treatment of high‐risk urothelial carcinoma of the upper urinary tract (UUT‐UC)
2011
Renal cell carcinoma
2017 Standout
Choice of Operation for Clinically Localized Renal Tumor
2008
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy
1997
Complex laparoscopic partial nephrectomy for renal hilar tumors
2005
Prognostic factors and selection for clinical studies of patients with kidney cancer
2007
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Risk Stratification of Men with Gleason Score 7 to 10 Tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database
2007
Nephron‐sparing surgery
2007
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
2010
The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis
2000
Robotic radical prostatectomy: A technique to reduce pT2 positive margins
2004 StandoutNobel
Perineural invasion in cancer
2009 Standout
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
Margin Status After Laparoscopic Radical Prostatectomy and the Index Lesion: Implications for Preoperative Evaluation of Tumor Focality in Prostate Cancer
2011
STAGE pT1 CONVENTIONAL (CLEAR CELL) RENAL CELL CARCINOMA: PATHOLOGICAL FEATURES ASSOCIATED WITH CANCER SPECIFIC SURVIVAL
2001
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens
2005
REEVALUATION OF THE 1997 TNM CLASSIFICATION FOR RENAL CELL CARCINOMA: T1 AND T2 CUTOFF POINT AT 4.5 RATHER THAN 7 CM. BETTER CORRELATES WITH CLINICAL OUTCOME
2001
Risk Factors for Complications and Morbidity After Radical Retropubic Prostatectomy
1997
POTENCY, CONTINENCE AND COMPLICATION RATES IN 1,870 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
1999
CHARACTERISTICS OF SCREENING DETECTED PROSTATE CANCER IN MEN 50 TO 66 YEARS OLD WITH 3 TO 4 NG./ML. PROSTATE SPECIFIC ANTIGEN
1998
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
2006
TESTOSTERONE SUPPLEMENTATION FOR ERECTILE DYSFUNCTION: RESULTS OF A META-ANALYSIS
2000
THE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE
2004
Prospective Analysis of Computerized Tomography and Needle Biopsy With Permanent Sectioning to Determine the Nature of Solid Renal Masses in Adults
2003
PROGNOSTIC FACTORS FOR SURVIVAL OF PATIENTS WITH PATHOLOGICAL GLEASON SCORE 7 PROSTATE CANCER: DIFFERENCES IN OUTCOME BETWEEN PRIMARY GLEASON GRADES 3 AND 4
2001
SYSTEMIC THERAPY FOR RENAL CELL CARCINOMA
2000
POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
2004
NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMES
2001
1653: Safety and Efficacy of Partial Nephrectomy for all T1 Tumors Based on an International Multicenter Experience
2004
LONG-TERM HAZARD OF PROGRESSION AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER: CONTINUED RISK OF BIOCHEMICAL FAILURE AFTER 5 YEARS
2000
Survival After Radical Prostatectomy
1997
RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERY
1999
Guidelines for the Primary Prevention of Stroke
2014 Standout
SALVAGE CRYOTHERAPY USING AN ARGON BASED SYSTEM FOR LOCALLY RECURRENT PROSTATE CANCER AFTER RADIATION THERAPY: THE COLUMBIA EXPERIENCE
2001
Complications of Radical and Partial Nephrectomy in a Large Contemporary Cohort
2004
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient Outcome
2002
Pharmacology of Penile Erection
2001
Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer
2008
Comparison Between Standard Flank Versus Laparoscopic Nephrectomy for Benign Renal Disease
1995
PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCER
2000
THE ORAL EFFICACY OF VARDENAFIL HYDROCHLORIDE FOR INDUCING PENILE ERECTION IN A CONSCIOUS RABBIT MODEL
2001
The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
2009 Standout
SURGICAL MANAGEMENT OF RENAL TUMORS 4 CM. OR LESS IN A CONTEMPORARY COHORT
2000
MANAGEMENT OF SMALL SOLITARY UNILATERAL RENAL CELL CARCINOMAS: IMPACT OF CENTRAL VERSUS PERIPHERAL TUMOR LOCATION
1998
SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE
2004
Laparoscopic Live Donor Nephrectomy
1996 Standout
LONG-TERM RESULTS OF NEPHRON SPARING SURGERY FOR LOCALIZED RENAL CELL CARCINOMA: 10-YEAR FOLLOWUP
2000
Predicting Tumor Volume in Radical Prostatectomy Specimens From Patients With Prostate Cancer
2003
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
FACTORS PREDICTING RECOVERY OF ERECTIONS AFTER RADICAL PROSTATECTOMY
2000 Standout
RESULTS OF SALVAGE CRYOABLATION OF THE PROSTATE AFTER RADIATION: IDENTIFYING PREDICTORS OF TREATMENT FAILURE AND COMPLICATIONS
2001
Biomedical Importance of Indoles
2013 Standout
Patient Selection for Salvage Cryotherapy for Locally Recurrent Prostate Cancer After Radiation Therapy
1999
5-Year Outcomes of Laparoscopic Partial Nephrectomy
2006
Nephron Sparing Surgery for Appropriately Selected Renal Cell Carcinoma Between 4 and 7 Cm Results in Outcome Similar to Radical Nephrectomy
2004
Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
2007 Standout
Open Partial Nephrectomy for Tumor in a Solitary Kidney: Experience With 400 Cases
2006
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
NEPHRON SPARING SURGERY FOR CENTRAL RENAL TUMORS: EXPERIENCE WITH 33 CASES
2000
Extended Pelvic Lymphadenectomy In Patients Undergoing Radical Prostatectomy: High Incidence Of Lymph Node Metastasis
2002 Standout
Impact of obesity on clinical outcomes in robotic prostatectomy
2005 StandoutNobel
Cancer de la prostate
2007
INTRAOPERATIVE AND POSTOPERATIVE COMPLICATIONS OF RADICAL RETROPUBIC PROSTATECTOMY IN A CONSECUTIVE SERIES OF 1,000 CASES
2001
Consensus statement: Guidelines for PSA following radiation therapy1
1997 Standout
Works of Seth E. Lerner being referenced
Relationship between contraction and relaxation in human and rabbit corpus cavernosum
1993
Combined laparoscopic pelvic lymph node dissection and modified belt radical perineal prostatectomy for localized prostatic adenocarcinoma
1994
Morbidity of contemporary radical retropubic prostatectomy for localized prostate cancer.
1995
Preoperative Laparoscopic Localization of the Nonpalpable Testis: A Critical Analysis of a 10-Year Experience
1994
Extended Experience With Radical Prostatectomy for Clinical Stage T3 Prostate Cancer: Outcome and Contemporary Morbidity
1995
Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery
2002
Disease Outcome in Patients With Low Stage Renal Cell Carcinoma Treated With Nephron Sparing or Radical Surgery
1996
Platinum-Chemotherapy for Advanced Transitional Cell Carcinoma of the Upper Urinary Tract
1996
Cytoreductive Surgery for Stage IV Renal Cell Carcinoma
1995
DEOXYRIBONUCLEIC ACID PLOIDY AND SERUM PROSTATE SPECIFIC ANTIGEN PREDICT OUTCOME FOLLOWING SALVAGE PROSTATECTOMY FOR RADIATION REFRACTORY PROSTATE CANCER
1999
USE OF SPIRAL COMPUTERIZED TOMOGRAPHY IN LIEU OF ANGIOGRAPHY FOR PREOPERATIVE ASSESSMENT OF LIVING RENAL DONORS
1999
Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.
1997
Prostate Specific Antigen Detected Prostate Cancer (Clinical Stage T1C): An Interim Analysis
1996
Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic Prostatectomy
1996
Reassessment of the Value of Post-Vascularization Biopsy Performed at Renal Transplantation: The Effects of Arteriosclerosis
1994
Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.
1996
Critical Evaluation of Salvage Surgery for Radio-Recurrent/Resistant Prostate Cancer
1995
Disease Outcome in Patients With Low Stage Renal Cell Carcinoma Treated With Nephron Sparing or Radical Surgery
1996
A Review of Erectile Dysfunction: New Insights and More Questions
1993
Endothelin-1 as a Putative Modulator of Erectile Dysfunction: I. Characteristics of Contraction of Isolated Corporal Tissue Strips
1995